Jun 05, 2023 2023 Global M&A Intelligence Report – Life Sciences Supplement By Victoria Rhodes Robert Newman The DLA Piper Life Sciences sector team is delighted to announce the launch of our new 2023 Global M&A Intelligence Report – Life...
Jun 05, 2023 Unlocking the Potential of AI in Life Sciences and Healthcare: what do companies need to consider? By Nicholas Tyacke Greg Bodulovic Alexandra de Zwart Alex Horder Jordan Davis +2 more... Show less The artificial intelligence (AI) revolution is simultaneously one of the biggest opportunities and challenges facing professionals,...
Jun 02, 2023 Poland - Life Sciences Monthly Brief, May 2023 By Andrzej Balicki, Ph.D. Jolanta Dabrowicz Przemysław Matuszewski Urszula Grębowska +1 more... Show less Download a copy of our May monthly briefing, which covers key updates and insights in the following areas: Medical devicesClinical...
May 31, 2023 Expert witnesses in Australian patent litigation - Recent federal court decisions reinforce the need to choose your expert witnesses carefully By Nicholas Tyacke Robynne Sanders Greg Bodulovic Alexandra de Zwart Jordan Davis +2 more... Show less The role of the expert witness is often crucial in Australian patent litigation, especially where the invention in question is...
May 30, 2023 Innovation Industries: The hot topic in global life sciences merger control By Alexandra Kamerling Claus Wenzler 1. Overview Mergers and acquisitions in innovation industries, and in particular in the life sciences sector, have experienced increased...
May 29, 2023 EU Pharma Law Forum 2023 - competition highlights By Joost Haans On 23 May 2023, Joost Haans from our Life Sciences team attended the EU Pharma Law Forum in Brussels where he participated in the...
May 26, 2023 Regulatory enforcement on the horizon for online prescriptions in Australia By Greg Bodulovic Nicholas Tyacke Tudor Filaret Hazel Pang Alex Horder +2 more... Show less As a result of the COVID-19 pandemic, the use of telehealth services has grown exponentially in Australia over the past three years. ...
May 26, 2023 EU Pharma Law Revision: First Reactions and Next Steps By Marco de Morpurgo Laetitia Mouton Mary Foord-Weston Exactly one month ago, on 26 April 2023, the European Commission (EC) adopted its long-awaited proposal for the revision of the EU...
May 19, 2023 Brazilian Health Regulatory Agency updates regulation that governs requirements for clinical laboratory tests By Bruna Rocha Juliana Marcondes Victoria Cristofaro On May 3rd of this year, Anvisa approved Resolution No. 786/2023 ("RDC 786/2023"), which addresses the technical and health requirements...
May 16, 2023 The future of the assisted reproductive technology (ART): Modernising ART processes with AI By Nicholas Tyacke Greg Bodulovic Alexandra de Zwart Abi Ketheeswaran +1 more... Show less Assisted fertilisation processes involve striking the perfect balance between a range of complex factors – all of which play a critical...
May 11, 2023 Poland - Life Sciences Monthly Brief, April 2023 By Andrzej Balicki, Ph.D. Jolanta Dabrowicz Przemysław Matuszewski Urszula Grębowska +1 more... Show less Download a copy of our April monthly briefing, which covers key updates and insights in the following areas: Medical devices; Clinical...
May 10, 2023 Life sentence: teaching large language models to read the book of life By Gareth Stokes Michael Stead Now you’re talking… If you’ve used one of the recent high-profile AI chatbots, then you’ve no doubt been wowed by their capability. If...
May 05, 2023 Significant vaping restrictions and tobacco control measures announced in Australia By Greg Bodulovic Nicholas Tyacke Tudor Filaret Hazel Pang +1 more... Show less On 2 May 2023, the Australian Federal Government announced a strong and measurable action plan to support their campaign in stamping out...
Apr 28, 2023 The UK voluntary scheme for branded medicines pricing and access (VPAS): just what the doctor ordered, or a bitter pill to swallow? By Michael Stead Martha Pownall On the 1 April this year, amidst storm clouds gathering above the NHS in the form of staffing strikes, record waiting times and chronic...
Apr 25, 2023 The Czech government is planning a regulated cannabis market By Jan Metelka Dylan Kennett The Czech government has announced its plan to introduce a highly regulated cannabis market in the Czech Republic. Currently, cannabis is...
Apr 20, 2023 Cross-border considerations for privacy in clinical trials - At the Intersection of Sciences and Law Podcast Series By James Clark Paula Gonzalez de Castejón Llano-Ponte David Kopans In this episode of At the Intersection of Sciences and Law Podcast Series, in light of the recent publication of our Cross-border Guide...